Traditional Chinese Medicine Market expected to grow at a CAGR of 5.1% to reach US$ 49.6 Bn by the end of 2033
The Global revenue from the Traditional Chinese Medicine Market was around US$ 28.7 Billion in 2022, with the global market expected to grow at a CAGR of 5.1% to reach a valuation of around US$ 49.6 Billion by the end of 2033.
The Traditional Chinese Medicine (TCM) market has witnessed significant growth and popularity over the years. TCM is a holistic system of medicine that has been practiced for thousands of years in China and other parts of Asia. It is based on the principles of balancing yin and yang energies and promoting the flow of Qi, or vital energy, throughout the body. The TCM market encompasses various products and therapies, including herbal medicines, acupuncture, massage, and dietary supplements.
The Global revenue from the Traditional Chinese Medicine Market was around US$ 28.7 Billion in 2022, with the global market expected to grow at a CAGR of 5.1% to reach a valuation of around US$ 49.6 Billion by the end of 2033.
One of the key drivers of the TCM market is the increasing demand for natural and alternative healthcare solutions. Many people are seeking alternatives to Western medicine, which often relies heavily on pharmaceutical drugs. TCM offers a more holistic approach that focuses on restoring balance and harmony in the body. Moreover, the rise in chronic diseases and lifestyle disorders has also contributed to the growing interest in TCM, as it offers a comprehensive and personalized treatment approach.
Companies
Tongrentang
Zhongxin Pharmaceuticals
Tianjin Tasly Group
Yuannan Baiyao
Solstice Medicine Company, Inc.
Shanghai Sundise Traditional Chinese Medicine Co., Ltd
China Chinese Medicine Holding Co., Ltd.
Hunan goldliloo pharmaceutical Co., Ltd
Wanbang Pharma Group Corp.
Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
Pfizer Inc.
Eli Lilly and Company
Novartis AG
GlaxoSmithKline PLC
Mallinckrodt Pharmaceuticals
Hisamitsu Pharmaceutical Co., Inc.
China, being the birthplace of TCM, plays a crucial role in the TCM market. The country has a rich heritage and extensive knowledge in traditional medicine, which has been passed down through generations. The Chinese government has actively supported the development and promotion of TCM, investing in research, infrastructure, and education. This has led to the establishment of numerous TCM hospitals, clinics, and research institutes, creating a robust market for TCM products and services.
In recent years, there has been an increasing global demand for TCM products. Traditional Chinese herbal medicines, such as ginseng, astragalus, and ginkgo biloba, have gained popularity worldwide. TCM dietary supplements, which often combine multiple herbal ingredients, are also being embraced by health-conscious consumers. Additionally, acupuncture, a key component of TCM, has gained recognition and acceptance in many countries as an effective treatment for various conditions, including pain management and stress reduction.
However, the TCM market is not without challenges. One of the main concerns is the quality control and standardization of TCM products. As the demand for TCM increases, there is a need for rigorous testing and regulation to ensure the safety and efficacy of these products. Furthermore, the integration of TCM with modern healthcare systems poses challenges in terms of training, research, and acceptance by medical professionals.
Competition Landscape
Exclusive distributorship for research and development, manufacturing and commercial purpose are few key strategies opted by leading players within this market space.
Some key instances of development include:
In 2020, Tianjin Tasly Group and Takara Bio collaborated for exclusive development, manufacturing and commercialization of Oncolytic Virus C-REV in China.
In July 2018, GSK signed an agreement with 23andMe to develop novel medicine thereby, leveraging genetic insights for new subsets of disease and enable rapid progression of clinical programs.
Key Segments Covered in Traditional Chinese Medicine Industry Research
Product:
Traditional Chinese Medicine (TCM)
Autism Spectrum Disorder (ASD)
Attention Deficit Hyperactivity Disorder (ADHD)
Non-Traditional Chinese Medicine (Non-TCM)
Autism Spectrum Disorder (ASD)
Attention Deficit Hyperactivity Disorder (ADHD)
Disease:
Autism Spectrum Disorder (ASD)
Attention Deficit Hyperactivity Disorder (ADHD)
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/traditional-chinese-medicine-market-expected-to-grow-at-a-cagr-of-5-1-to-reach-us-49-6-bn-by-the-end-of-2033.html
相关推荐
-
(Chengdu Universiade) Embracing allure of TCM at FISU Games Village
From pulse diagnosis to rehabilitation services, traditional Chinese medicine (TCM) specialists are taking every measure to ensure athletes are in tip-top shape at the FISU Games Village, which is housing those participating in the ongoing 31st FISU World University Games in Chengdu, the capital city of southwest China’s Sichuan Province.
-
Traditional Chinese medicine finding right Rx for global success
Data from the China Chamber of Commerce for Import and Export of Medicines and Health Products showed that TCM exports surged 21.4 percent on a yearly basis to about $2.8 billion during the first half.
-
Special Report – “Dangerous” or “effective” treatment?
Although it’s not known whether anyone has been cured of COVID-19 using only traditional Chinese medicine (TCM), in the last year and a half dozens of scientific articles have been published on the merits of TCM in combating the pandemic. According to the paper Traditional Chinese medicine for COVID-19 treatment, “COVID-19 treatment practice has shown that early intervention with TCM is an important way to improve cure rate, shorten the course of disease, delay disease progression and reduce mortality rate. Furthermore, the reasons why TCM works could include not only…
-
China composes TCM therapy for patients with Omicron by studying their syndromes
A pharmacist fulfills a Chinese Traditional Medicine (TCM) prescription at Gansu Provincial Hospital of Traditional Chinese Medicine (TCM) in Lanzhou, northwest China’s Gansu Province, Oct. 23, 2021. (Xinhua) China will study traditional Chinese medicine (TCM) therapy to treat patients with the Omicron strain, experts with the National Administration of Traditional Chinese Medicine said on Thursday. Practitioner said TCM could play a bigger role in COVID-19 treatment if patients with the Omicron strain showed mild symptoms or none, as studies showed, as TCM has proven effective in treating COVID-19 patients through…
-
China Exports Its Traditional Medicine to Africa
In Kenya, Hing Pal Singh is one of the patients who visits the Oriental Chinese Herbal Clinic in the capital, Nairobi. Singh is 85 years old. He has had problems with his back for five years. Singh is now trying herbal treatments. These are medicines made from plants. “There is a slight difference,” Singh said. “… It’s only a week now. It will take at least another 12 to 15 sessions. Then we see how it goes.” A 2020 study from the Beijing research group Development Reimagined, said that traditional…
-
Study Finds Traditional Chinese Medicine Is As Effective as Drugs in Treating a Certain Type of Infection
A clinical trial demonstrates that Yupingfeng, a traditional Chinese medicine, is as effective as allopathic drugs at treating children with recurrent respiratory tract infections.
-
Covid-19: Mainland traditional Chinese medicine experts in Hong Kong offer treatment guidelines
A group of mainland Chinese experts have met with Hong Kong health officials to draft plans to use traditional Chinese medicine in Covid-19 clinical treatment as the city’s fifth-wave case fatality rate climbs. Secretary for Food and Health Sophia Chan met with the experts sent by the central authorities on Tuesday. The group, which arrived in the city last Tuesday, is part of Beijing’s efforts to aid the city’s anti-epidemic efforts, according to a government statement. Since their arrival, the delegation of seven traditional Chinese medicine experts has visited elderly…
-
Traditional Chinese medicine enters global stage
The Traditional Chinese Medicine (TCM) practices of acupuncture and moxibustion have been inscribed ion UNESCO’s Representative List of Intangible Cultural Heritage of Humanity since 2010.
-
Hospitals enhance rehab and TCM on post-COVID symptoms
According to Dr Liu Danwei from Shanghai Yida Hospital, the hospital’s outpatient clinic for recovered COVID-19 patients consists of doctors from departments of general medicine, respiratory disease, neurology, TCM, cardiology, health checkups, rehabilitation and radiation.
-
Sunbathing increasingly popular due to link with TCM therapy
In fact, some of the Chinese fans of sunbathing wear head-to-toe sun-protective clothing when enjoying the sunshine as their aim is not to tan their skin, but to boost their yang qi – a vital energy in traditional Chinese medicine (TCM).
